Sunshine Biopharma Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Steve Slilaty (70 yo)





Dr. Steve N. Slilaty, Ph D., serves as the President, Chief Executive Officer and Chief Scientific Officer of Advanomics Corporation since February 2002. Dr. Slilaty serves as the Chairman, Chief Executive...

CEO Compensation Analysis

Steve Slilaty's Compensation vs Sunshine Biopharma Earnings
How has Steve Slilaty's remuneration changed compared to Sunshine Biopharma's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021US$462kUS$156k


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020US$227kUS$177k


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020n/an/a


Dec 31 2019US$96kUS$28k


Sep 30 2019n/an/a


Jun 30 2019n/an/a


Mar 31 2019n/an/a


Dec 31 2018US$285kUS$85k


Sep 30 2018n/an/a


Jun 30 2018n/an/a


Mar 31 2018n/an/a


Dec 31 2017US$268kUS$156k


Sep 30 2017n/an/a


Jun 30 2017n/an/a


Mar 31 2017n/an/a


Dec 31 2016US$166kUS$1k


Sep 30 2016n/an/a


Jun 30 2016n/an/a


Mar 31 2016n/an/a


Dec 31 2015US$50kn/a


Compensation vs Market: Steve's total compensation ($USD462.38K) is below average for companies of similar size in the US market ($USD772.75K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.

Leadership Team

Experienced Management: SBFM's management team is seasoned and experienced (13 years average tenure).

Board Members

Experienced Board: SBFM's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.